These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12486318

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Measurement of anti-factor VIII IgG, IgG4 and IgM alloantibodies in previously untreated hemophilia A patients treated with recombinant factor VIII. Kogenate Japanese Clinical Study Group.
    Shima M, Sawamoto Y, Nakai H, Kamisue S, Murakami T, Morichika S, Tanaka I, Hayashi K, Yoshioka A.
    Int J Hematol; 1995 Jul; 62(1):35-43. PubMed ID: 7670006
    [Abstract] [Full Text] [Related]

  • 25. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII.
    Koshihara K, Qian J, Lollar P, Hoyer LW.
    Blood; 1995 Sep 15; 86(6):2183-90. PubMed ID: 7662967
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of nonneutralizing antibodies against factor VIII in severe haemophilia A patients from India.
    David S, Mathews NS, Singh GS, Korula A, Aboobacker FN, Abraham A, George B, Srivastava A, Mathews V, Nair SC.
    Blood Coagul Fibrinolysis; 2019 Oct 15; 30(7):337-340. PubMed ID: 31449137
    [Abstract] [Full Text] [Related]

  • 27. Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A.
    Lindgren A, Wadenvik H, Tengborn L.
    Haemophilia; 2002 Sep 15; 8(5):644-8. PubMed ID: 12199673
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alloantibodies to factor VIII in haemophilia.
    Zakarija A, Harris S, Rademaker AW, Brewer J, Krudysz-Amblo J, Butenas S, Mann KG, Green D.
    Haemophilia; 2011 Jul 15; 17(4):636-40. PubMed ID: 21299745
    [Abstract] [Full Text] [Related]

  • 32. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA, Tucunduva AC, Siqueira LH, Sambo AL, Medina SS, Ozelo MC.
    Haemophilia; 2015 Sep 15; 21(5):686-92. PubMed ID: 25708525
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. ELISA for factor VIII antibodies: does it detect antibodies much before the conventional Bethesda assay?
    Shetty S, Ghosh K, Mohanty D.
    Haemophilia; 2003 Sep 15; 9(5):654. PubMed ID: 14511311
    [No Abstract] [Full Text] [Related]

  • 37. Immunological characterization of factor VIII inhibitors by a sensitive micro-ELISA method.
    Sánchez-Cuenca JM, Carmona E, Villanueva MJ, Aznar JA.
    Thromb Res; 1990 Mar 15; 57(6):897-908. PubMed ID: 2116682
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Inhibitors in haemophilia A: current management and open issues.
    Haya S, Moret A, Cid AR, Cortina V, Casaña P, Cabrera N, Aznar JA.
    Haemophilia; 2007 Dec 15; 13 Suppl 5():52-60. PubMed ID: 18078398
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.